Scale Venture Partners is a long-standing partnership with a track record of top-quartile returns that has become a go-to firm in our chosen markets. We have over $1.2B under management, and have worked together as a partnership for over ten years. We are currently investing Scale Venture Partners III, a $250M fund.

ScaleVP focuses on investments in mid- to late-stage information technology and healthcare companies that are positioned for high growth in large markets. This investment strategy has allowed us to build a compelling portfolio in terms of risk, return and time to liquidity. We first work to identify large, attractive markets, and then use proactive deal sourcing to seek out the best companies within those markets. In addition, we put our go-to-market operating backgrounds to work in helping portfolio companies efficiently scale their business and prepare for an exit.

We are proud to have successfully identified and invested in dozens of high-growth companies and have a track record of investing in markets such as software-as-a-service, power management semiconductors and central nervous system therapeutics. Portfolio companies include Omniture, Frontbridge, Monolithic Power Systems, Entone, Cellective, Orexigen, National Healing, Everyday Health and Glu Mobile.

We are active investors and board members who use our industry expertise to catalyze value. Our portfolio companies benefit from our market knowledge and experience building companies. ScaleVP delivers access to its network of entrepreneurs and experts to help continue to build value and create successful, repeat entrepreneurs.

For information about Scale Venture Partners,
please contact .